Antal Bajor

1.8k total citations
30 papers, 1.3k citations indexed

About

Antal Bajor is a scholar working on Gastroenterology, Surgery and Epidemiology. According to data from OpenAlex, Antal Bajor has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Gastroenterology, 15 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Antal Bajor's work include Gastrointestinal motility and disorders (11 papers), Microscopic Colitis (11 papers) and Gastroesophageal reflux and treatments (9 papers). Antal Bajor is often cited by papers focused on Gastrointestinal motility and disorders (11 papers), Microscopic Colitis (11 papers) and Gastroesophageal reflux and treatments (9 papers). Antal Bajor collaborates with scholars based in Sweden, United States and Australia. Antal Bajor's co-authors include Magnus Simrén, Hans Strid, Kjell–Arne Ung, Hasse Abrahamsson, Riadh Sadik, Mats Rudling, Per‐Göran Gillberg, Lena Öhman, Hans Törnblom and Maria K. Magnusson and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

Antal Bajor

29 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Antal Bajor 680 527 316 302 224 30 1.3k
Pontus Karling 313 0.5× 347 0.7× 339 1.1× 385 1.3× 347 1.5× 65 1.3k
George Karamanolis 920 1.4× 1.0k 2.0× 137 0.4× 119 0.4× 170 0.8× 73 1.7k
Stefan Isaksson 438 0.6× 334 0.6× 356 1.1× 430 1.4× 239 1.1× 29 1.0k
Thierry Piche 633 0.9× 660 1.3× 222 0.7× 125 0.4× 125 0.6× 53 1.3k
David S. Sanders 1.3k 1.9× 740 1.4× 770 2.4× 275 0.9× 164 0.7× 73 2.0k
Reza Ansari 430 0.6× 354 0.7× 268 0.8× 102 0.3× 93 0.4× 45 1.1k
A Torsoli 742 1.1× 1.0k 2.0× 463 1.5× 422 1.4× 327 1.5× 77 2.1k
Stéphane Lecleire 770 1.1× 957 1.8× 136 0.4× 82 0.3× 244 1.1× 59 1.7k
Jun Gao 439 0.6× 691 1.3× 90 0.3× 66 0.2× 321 1.4× 62 1.5k
W Tillinger 202 0.3× 297 0.6× 674 2.1× 825 2.7× 154 0.7× 27 1.6k

Countries citing papers authored by Antal Bajor

Since Specialization
Citations

This map shows the geographic impact of Antal Bajor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antal Bajor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antal Bajor more than expected).

Fields of papers citing papers by Antal Bajor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antal Bajor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antal Bajor. The network helps show where Antal Bajor may publish in the future.

Co-authorship network of co-authors of Antal Bajor

This figure shows the co-authorship network connecting the top 25 collaborators of Antal Bajor. A scholar is included among the top collaborators of Antal Bajor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antal Bajor. Antal Bajor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frigstad, Svein Oskar, Anne Haaber, Antal Bajor, et al.. (2017). The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency. Gastroenterology Research and Practice. 2017. 1–7. 16 indexed citations
2.
3.
Almér, Sven, Anders Eriksson, Pontus Karling, et al.. (2016). Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients. Alimentary Pharmacology & Therapeutics. 45(4). 519–532. 26 indexed citations
4.
Magnusson, Maria K., Hans Strid, Maria Sapnara, et al.. (2016). Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition. Journal of Crohn s and Colitis. 10(8). 943–952. 139 indexed citations
5.
Stotzer, Per‐Ove, Hasse Abrahamsson, Antal Bajor, et al.. (2015). Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea. United European Gastroenterology Journal. 3(4). 381–386. 18 indexed citations
6.
Dahlén, Rahil, Maria K. Magnusson, Antal Bajor, et al.. (2015). Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy. Scandinavian Journal of Gastroenterology. 50(9). 1118–1126. 42 indexed citations
7.
Bajor, Antal, Hans Törnblom, Mats Rudling, Kjell–Arne Ung, & Magnus Simrén. (2014). Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. Gut. 64(1). 84–92. 158 indexed citations
8.
Magnusson, Maria K., Hans Strid, Stefan Isaksson, et al.. (2014). Response to Infliximab Therapy in Ulcerative Colitis is Associated With Decreased Monocyte Activation, Reduced CCL2 Expression and Downregulation of Tenascin C. Journal of Crohn s and Colitis. 9(1). 56–65. 38 indexed citations
9.
Magnusson, Maria K., Rahil Dahlén, Hans Strid, et al.. (2013). CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis. United European Gastroenterology Journal. 1(6). 467–476. 11 indexed citations
10.
Befrits, Ragnar, Ola Wikman, Lars Blomquist, et al.. (2013). Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life. Scandinavian Journal of Gastroenterology. 48(9). 1027–1032. 29 indexed citations
11.
Magnusson, Maria K., Hans Strid, Rahil Dahlén, et al.. (2012). Sa1901 T Cell Expression of CD25 and TNF Receptor 2 is Associated With Anti-TNF Therapy Response in Patients With Inflammatory Bowel Disease. Gastroenterology. 142(5). S–354.
12.
Simrén, Magnus, et al.. (2011). Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation - a double-blind study. Alimentary Pharmacology & Therapeutics. 34(1). 41–50. 96 indexed citations
13.
Simrén, Magnus, et al.. (2011). Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled Trial. The American Journal of Gastroenterology. 106(5). 915–922. 249 indexed citations
14.
Simrén, Magnus, Hasse Abrahamsson, Antal Bajor, & H. Graffner. (2010). S1299 The IBAT Inhibitor A3309 – A Promising Treatment Option for Patients With Chronic Idiopathic Constipation (Cic). Gastroenterology. 138(5). S–223. 6 indexed citations
15.
Ung, Kjell–Arne, et al.. (2009). Biliary sphincterotomy does not relate to diarrhoea or major changes in bile acid synthesis or plasma lipids. Scandinavian Journal of Gastroenterology. 44(9). 1132–1138. 1 indexed citations
16.
Bajor, Antal, Kjell–Arne Ung, Lena Öhman, et al.. (2009). Indirect evidence for increased mechanosensitivity of jejunal secretomotor neurones in patients with idiopathic bile acid malabsorption. Acta Physiologica. 197(2). 129–137. 9 indexed citations
17.
Bajor, Antal, Anders Kilander, Henrik Sjövall, Mats Rudling, & Kjell–Arne Ung. (2008). The Bile Acid Turnover Rate Assessed with the 75SeHCAT Test Is Stable in Chronic Diarrhoea but Slightly Decreased in Healthy Subjects After a Long Period of Time. Digestive Diseases and Sciences. 53(11). 2935–2940. 16 indexed citations
18.
Bajor, Antal, Anders Kilander, Olof Jonsson, et al.. (2006). Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. European Journal of Gastroenterology & Hepatology. 18(4). 397–403. 43 indexed citations
19.
Bajor, Antal, Anders Kilander, Cecilia Gälman, Mats Rudling, & Kjell–Arne Ung. (2006). Budesonide treatment is associated with increased bile acid absorption in collagenous colitis. Alimentary Pharmacology & Therapeutics. 24(11-12). 1643–1649. 45 indexed citations
20.
Niklasson, Anna, et al.. (2003). Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases. Respiratory Medicine. 97(10). 1143–1150. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pontus Karling Breakdown of academic impact, for papers by George Karamanolis Breakdown of academic impact, for papers by Stefan Isaksson Breakdown of academic impact, for papers by Thierry Piche Breakdown of academic impact, for papers by David S. Sanders Breakdown of academic impact, for papers by Reza Ansari Breakdown of academic impact, for papers by A Torsoli Breakdown of academic impact, for papers by Stéphane Lecleire Breakdown of academic impact, for papers by Jun Gao Breakdown of academic impact, for papers by W Tillinger
Rankless by CCL
2026